Works matching DE "BULLOUS pemphigoid"
Results: 2086
Corticosteroids are still first-line therapies for bullous pemphigoid, with biologics finding use in difficult-to-treat disease.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 310, doi. 10.1007/s40267-024-01085-6
- By:
- Publication type:
- Article
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor – A case report.
- Published in:
- Journal of Postgraduate Medicine, 2019, v. 65, n. 4, p. 244, doi. 10.4103/jpgm.JPGM_120_19
- By:
- Publication type:
- Article
A case of paraneoplastic bullous pemphigoid in association with squamous cell carcinoma of lung.
- Published in:
- Journal of Postgraduate Medicine, 2015, v. 61, n. 3, p. 197, doi. 10.4103/0022-3859.150906
- By:
- Publication type:
- Article
Psoriasis and Cardiovascular Risk in Children: The Usefulness of Carotid Intima-Media Thickness.
- Published in:
- Pediatric Cardiology, 2022, v. 43, n. 7, p. 1462, doi. 10.1007/s00246-022-02869-1
- By:
- Publication type:
- Article
Use of Bowman's membrane electrocautery in blind eyes with painful bullous keratopathy not amenable to corneal transplantation: a retrospective case series.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 1, p. 191, doi. 10.1007/s00417-021-05360-4
- By:
- Publication type:
- Article
Pemphigus Vulgaris and Bullous Pemphigoid of the Upper Aerodigestive Tract: A Review Article and Novel Approaches to Management.
- Published in:
- ORL, 2021, v. 83, n. 6, p. 395, doi. 10.1159/000515229
- By:
- Publication type:
- Article
Refractory bullous pemphigoid during treatment with pembrolizumab in the first-line treatment of advanced non-small cell lung cancer.
- Published in:
- Forum Dermatologicum, 2024, v. 10, n. 2, p. 54, doi. 10.5603/fd.100000
- By:
- Publication type:
- Article
Bullous pemphigoid in a young patient with coexisting long-standing psoriasis, successfully treated with methotrexate.
- Published in:
- Forum Dermatologicum, 2023, v. 9, n. 2, p. 75, doi. 10.5603/FD.a2023.0003
- By:
- Publication type:
- Article
Autoimmunologiczne choroby pęcherzowe skóry — analiza retrospektywna.
- Published in:
- Forum Dermatologicum, 2022, v. 8, n. 2, p. 93, doi. 10.5603/FD.a2022.0001
- By:
- Publication type:
- Article
Single cell transcriptome profiling reveals pathogenesis of bullous pemphigoid.
- Published in:
- Communications Biology, 2025, p. 1, doi. 10.1038/s42003-025-07629-4
- By:
- Publication type:
- Article
A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 1, p. 124, doi. 10.3906/sag-2006-231
- By:
- Publication type:
- Article
An elderly man with an intensely itchy skin eruption.
- Published in:
- Medicine Today, 2024, v. 25, n. 7, p. 55
- By:
- Publication type:
- Article
A widespread erythematous targetoid eruption.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
- Published in:
- Quintessence International, 2024, v. 55, n. 5, p. 400, doi. 10.3290/j.qi.b5031811
- By:
- Publication type:
- Article
Timely recognition of pemphigus vulgaris by dental professionals.
- Published in:
- Quintessence International, 2013, v. 44, n. 7, p. 521, doi. 10.3290/J.qi.a29614
- By:
- Publication type:
- Article
Staphylococcal Infections and Neonatal Skin: Data from Literature and Suggestions for the Clinical Management from Four Challenging Patients.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 632, doi. 10.3390/antibiotics12040632
- By:
- Publication type:
- Article
Severe Type of Minocycline-Induced Hyperpigmentation Mimicking Peripheral Arterial Occlusive Disease in a Bullous Pemphigoid Patient.
- Published in:
- Antibiotics (2079-6382), 2019, v. 8, n. 3, p. 93, doi. 10.3390/antibiotics8030093
- By:
- Publication type:
- Article
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1016, doi. 10.3390/vaccines12091016
- By:
- Publication type:
- Article
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 465, doi. 10.3390/vaccines12050465
- By:
- Publication type:
- Article
Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 73, doi. 10.3390/vaccines12010073
- By:
- Publication type:
- Article
Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 745, doi. 10.3390/vaccines10050745
- By:
- Publication type:
- Article
Pruritus as a Distinctive Feature of Type 2 Inflammation.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 303, doi. 10.3390/vaccines9030303
- By:
- Publication type:
- Article
Intratumoral Combinatorial Administration of CD1c (BDCA-1) + Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 670, doi. 10.3390/vaccines8040670
- By:
- Publication type:
- Article
Comparison of the use of blood pressure telemonitoring versus standard medical care in the achievement of short-term therapeutic goals in blood pressure in patients with uncontrolled hypertension: An open-label clinical trial.
- Published in:
- JRSM Cardiovascular Disease, 2023, p. 1, doi. 10.1177/20480040231178585
- By:
- Publication type:
- Article
Comparison of the use of blood pressure telemonitoring versus standard medical care in the achievement of short-term therapeutic goals in blood pressure in patients with uncontrolled hypertension: An open-label clinical trial.
- Published in:
- JRSM Cardiovascular Disease, 2023, v. 12, p. 1, doi. 10.1177/20480040231178585
- By:
- Publication type:
- Article
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 11, p. 1386, doi. 10.3390/brainsci11111386
- By:
- Publication type:
- Article
HLA-Cw6 Polymorphism in Autoimmune Blistering Diseases.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 9, p. 1150, doi. 10.3390/biom14091150
- By:
- Publication type:
- Article
Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1019, doi. 10.3390/biom13071019
- By:
- Publication type:
- Article
Dupilumab in Inflammatory Skin Diseases: A Systematic Review.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 4, p. 634, doi. 10.3390/biom13040634
- By:
- Publication type:
- Article
Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 3, p. 485, doi. 10.3390/biom13030485
- By:
- Publication type:
- Article
'Tis but a scratch: discussing the future of eczema treatment in the wake of a psoriasis revolution.
- Published in:
- New Zealand Medical Student Journal, 2020, n. 30, p. 26, doi. 10.57129/rmhr9201
- By:
- Publication type:
- Article
Facing the Challenge of Lowering Blood Pressure and Cholesterol in the Same Patient: Report of a Symposium at the European Society of Hypertension.
- Published in:
- Cardiology & Therapy, 2020, v. 9, n. 1, p. 19, doi. 10.1007/s40119-019-00159-1
- By:
- Publication type:
- Article
Dulaglutide‐related bullous pemphigoid in a patient with type 2 diabetes: A case report.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Bullous pemphigoid and percutaneous endoscopic gastrostomy.
- Published in:
- Geriatrics & Gerontology International, 2016, v. 16, n. 10, p. 1173, doi. 10.1111/ggi.12690
- By:
- Publication type:
- Article
Dipeptidyl peptidase- IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 3, p. 368, doi. 10.1111/jcpt.12397
- By:
- Publication type:
- Article
Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1124730
- By:
- Publication type:
- Article
Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1095694
- By:
- Publication type:
- Article
Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1176284
- By:
- Publication type:
- Article
Basophils in pruritic skin diseases.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1213138
- By:
- Publication type:
- Article
Comorbidity in bullous pemphigoid: up-date and clinical implications.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1196999
- By:
- Publication type:
- Article
Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1203776
- By:
- Publication type:
- Article
Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1135002
- By:
- Publication type:
- Article
Case Report: Localized bullous pemphigoid induced by local triggers: a case series and a proposal for diagnostic criteria based on a literature review.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1160779
- By:
- Publication type:
- Article
Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1201163
- By:
- Publication type:
- Article
Aberrant inflammasome activation as a driving force of human autoimmune skin disease.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1190388
- By:
- Publication type:
- Article
Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1179294
- By:
- Publication type:
- Article
Biological treatment for bullous pemphigoid.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1157250
- By:
- Publication type:
- Article
Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1159351
- By:
- Publication type:
- Article
Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1180150
- By:
- Publication type:
- Article
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1118539
- By:
- Publication type:
- Article